5-methylcytidine has been researched along with Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boonyayothin, W; Bychkov, A; Keelawat, S; Kitkumthorn, N; Mutirangura, A; Poumsuk, U; Rattanatanyong, P; Ruangvejvorachai, P; Shuangshoti, S; Thorner, PS | 1 |
Bova, GS; Brooks, JD; Campbell, PA; Epstein, JI; Hsieh, WS; Isaacs, WB; Lee, WH; Morton, RA; Nelson, WG | 1 |
2 other study(ies) available for 5-methylcytidine and Carcinoma
Article | Year |
---|---|
Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis.
Topics: Adenocarcinoma, Follicular; Adenoma; Carcinoma; Carcinoma, Papillary; Cytidine; DNA Methylation; Humans; Immunohistochemistry; Long Interspersed Nucleotide Elements; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2015 |
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
Topics: Carcinoma; Cytidine; DNA Topoisomerases, Type I; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Male; Methylation; Prostate; Prostatic Neoplasms; Regulatory Sequences, Nucleic Acid; Restriction Mapping; RNA, Messenger | 1994 |